More women can now get answers about their hereditary risk of breast and ovarian cancer with genetic method
There may be hopeful news ahead for families with a history of breast and ovarian cancer.
Jun 17, 2025
0
80
There may be hopeful news ahead for families with a history of breast and ovarian cancer.
Jun 17, 2025
0
80
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies. Scientists at UC San Francisco have found a way to identify and possibly treat a mysterious type of ...
Jun 17, 2025
0
33
Researchers at Northeastern University have identified two proteins abundant on drug-resistant ovarian cancer cells that become receptive to chemotherapy when treated with light.
Jun 16, 2025
0
0
Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive measures for various diseases. Through a new study, a nomogram ...
Jun 11, 2025
0
0
For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often harmed fertility. They also caused severe side effects and an uncertain prognosis.
Jun 3, 2025
0
0
Researchers at ETH Zurich have developed the first technology that is able to recognize biomarkers in menstrual blood—directly in sanitary towels. MenstruAI promises a simple, non-invasive method for recording health data ...
May 27, 2025
0
28
Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancers more common and more deadly. The rise in rates is small but statistically significant, ...
May 27, 2025
0
0
Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because current treatments are not effective once the cancer has spread (metastasized) beyond the ovaries.
May 13, 2025
0
8
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...
May 12, 2025
0
0
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the journal eClinicalMedicine finds that first-generation weight-loss medications like liraglutide and ...
May 12, 2025
0
32